João Pedro Martins

João Pedro Martins

Auto-generated profile, based on publicly available information

João Pedro Martins

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2018 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
JMJoão Pedro Martins
João Pedro Martins
GTGiulia Torrieri
Giulia Torrieri
Hélder SantosHélder Santos
Hélder Santos
Nanoparticles are anticipated to overcome persistent challenges in efficient drug delivery, but the limitations associated with conventional methods of preparation are resulting in slow translation from research to clinical applications. Due to their enormous potential, microfluidic technologies have emerged as an advanced approach for the development of drug delivery systems with well-defined physicochemical characteristics and in a reproducible manner. This review provides an overview of microfluidic devices and materials used for their manufacturing, together with the flow patterns and regimes commonly used for nanoparticle preparation. Additionally, the different geometries used in droplet microfluidics are reviewed, with particular attention to the co-flow geometry used for the production of nanoparticles. Finally, this review summarizes the main and most recent nanoparticulate systems prepared using microfluidics, including drug nanosuspensions, polymeric, lipid, structured, and theranostic nanoparticles. The production of nanoparticles at industrial scale is still a challenge, but the microfluidic technologies bring exciting opportunities to develop drug delivery systems that can be engineered in an easy, cost-effective and reproducible manner. As a highly interdisciplinary research field, more efforts and general acceptance are needed to allow for the translation of nanoparticulate drug delivery systems from academic research to the clinical practice.

5 March 2020 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
JMJoão Pedro Martins
João Pedro Martins
JNJosé das Neves
José das Neves
MFMaría de la Fuente
María de la Fuente
Christian CeliaChristian Celia
Christian Celia
HFHelena Florindo
Helena Florindo
Hélder SantosHélder Santos
Hélder Santos
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.

1 May 2016 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
JMJoão Pedro Martins
João Pedro Martins
PKPatrick J. Kennedy
Patrick J. Kennedy
Hélder SantosHélder Santos
Hélder Santos
CBCristina Carvalho Barrias
Cristina Carvalho Barrias
Bruno SarmentoBruno Sarmento
Bruno Sarmento

16 October 2018 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
SBSerena Bertoni
Serena Bertoni
ZLZehua Liu
Zehua Liu
ACAlexandra Correia
Alexandra Correia
JMJoão Pedro Martins
João Pedro Martins
ARAntti Rahikkala
Antti Rahikkala
Hélder SantosHélder Santos
Hélder Santos

4 September 2017 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
TBTomás Bauleth‐Ramos
Tomás Bauleth‐Ramos
Mohammad-Ali ShahbaziMohammad-Ali Shahbazi
Mohammad-Ali Shahbazi
DLDongfei Liu
Dongfei Liu
FFFlavia Fontana
Flavia Fontana
ACAlexandra Correia
Alexandra Correia
Hélder SantosHélder Santos
Hélder Santos

1 August 2017 in Progress in Materials Science
Verified
Journal Article
Closed access
FAFrancisca Araújo
Francisca Araújo
José das NevesJosé das Neves
José das Neves
JMJoão Pedro Martins
João Pedro Martins
Pedro GranjaPedro Granja
Pedro Granja
HSHélder A. Santos
Hélder A. Santos
Bruno SarmentoBruno Sarmento
Bruno Sarmento